The New York Cannabis Control Board (CCB) made it clear on Wednesday – controversial delta-8 THC products cannot be sold, though hemp flower is allowed. The clarification comes some eight months after former Governor Andrew Cuomo reported Marijuana Moment.
Empire State regulators also approved the sale of hemp-infused food and beverages,
Considering the complexity of the program such as legal marijuana, New York is still figuring out which rules and guidelines are needed to make it function properly. The new rules and clarifications are often coming, and the state just recently made a really bold move becoming the first in the Union to prohibit employers from testing most employees for cannabis, setting up all the rules on cannabis in the workplace.
The Anticipated Ban On Delta-8 THC Is Here
Among the many issues taken up by the CCB Wednesday, including advertising, labeling, packaging and lab testing, the most anticipated among cannabis companies and consumers was the decision regarding
delta-8 THC, an intoxicating component in the cannabis plant that can be converted from CBD derived from hemp.
Just recently, a study revealed another problem with delta-8 products that being too much mislabeling involved. Many argued that the mislabeling issues is just another reason for lawmakers to ban these products, which in the case of New York turned out to be true. In this way, the state has officially joined others prohibiting delta-8 THC products such as Texas, Colorado, Oregon, Utah, and Washington to name a few.
The CCB made clear that its new regulations “prohibit the sale of Delta-8 THC products,” and because they contain intoxicating qualities they "are better left to be regulated in the future Adult-Use program.”
The board further declared a 60-day public comment period, during which people can weigh in on a draft proposal to permit medical cannabis patients to cultivate their own plants.
As for the hemp flower, the rules are set – those product are allowed for sale but not to be advertised “for the purpose of smoking or be in the form of a pre-roll, cigar or joint.”
“We are working as quickly as we can to build a new, safe industry that promotes public health and grows our economy, and with today’s approval of hemp regulations, we are taking another step forward in delivering on that promise for New Yorkers,” CCB chair Tremaine Wright stated. “In just our first month of operating, we have already made it easier for patients to access medical cannabis.”
Photo: Courtesy of Colton Duke on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.